Sanofi Stock News

Shares of MeiraGTx Holdings PLC MGTX, -4.88% jumped 14% premarket on Monday after the gene therapy company announced that French drugmaker Sanofi SNY, -19.13% has made a $30 million investment.

Sanofi (NASDAQ:SNY ) Q3 2023 Earnings Conference Call October 27, 2023 9:00 AM ET Company Participants Eva Schaefer-Jansen - Head of Investor Relations Paul Hudson - Chief Executive Officer Jean-Bapti

Sanofi (SNY) beats third-quarter estimates for earnings but misses the same for sales. It announces plans to separate its Consumer unit into a new public listed company.

Sanofi (NYSE: SNY ) stock fell about 15% overnight after it predicted slower profit growth next year. The French drug company also said it will follow rivals and spinoff its consumer health business.

Sanofi CEO Paul Hudson joins 'Squawk Box' to discuss the company's quarterly earnings results, spin off of its consumer health care business, growth outlook, and more.

Shares of French drugmaker Sanofi fell as much as 16% on Friday after after hiking its research-and-development expense guidance as well as its expectations for taxes.

Intel Corp. stock INTC, -0.94% jumped 8% after the chipmaker beat expectations for its third quarter and delivered an upbeat forecast for the current quarter.

Sanofi on Friday mapped out a potential separate listing of its consumer healthcare business from the fourth quarter of next year, as it plans to shore up new drug development spending at its core bus

Sanofi SA, the French pharmaceutical company, has announced plans to potentially separate its consumer healthcare division by listing it on the capital markets by the end of next year. If the IPO occu

Sanofi (FRA: SNW), the giant healthcare company, is considering spinning off its consumer health business. In a statement, the management said it was hoping to create a separate company listed in Fran

French drugmaker Sanofi said on Friday it was looking into the separate listing of its Consumer Healthcare business from the fourth quarter of next year and that it plans to boost drug development at

French drugmaker Sanofi said on Friday it was seeing an "unprecedented level" of demand for its antibody therapy to prevent respiratory syncytial virus (RSV), a leading cause of hospitalizations in in

GoodRx said on Thursday it has collaborated with Sanofi to offer the drugmaker's most-prescribed insulin injection Lantus for only $35 through its digital marketplace in the U.S.

Sanofi SNY, +0.07% on Friday released positive trial results for its investigational eczema treatment, notching a win that stemmed from the company's recent dealmaking to bolster its immunology pipeli

Scientists Katalin Karikó and Drew Weissman were awarded the Nobel prize this week for a discovery that went under the radar for many years, until it was found to hold the key to stabilising mRNA v